Advances in Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer

By sjmartinez • June 12, 2023

Ziyeh S, Wong L, Basho RK. Advances in Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer. Curr Oncol Rep. 2023 Jul;25(7):689-698. doi: 10.1007/s11912-023-01393-6. Epub 2023 Apr 1. PMID: 37004700.

Tags: AKT inhibition, CDK4/6 inhibition, CERANs, Endocrine therapy, Fellow, General Internal Medicine, Hematology/Oncology, HER2 negative breast cancer, Hormone receptor-positive breast cancer, Olive View DoM, PI3K inhibition, PIK3CA mutation, PROTACs, Publications, SARMs, SERCAs, SERDs, SERMs

William J. Carroll, MD, FACP Appointed Section Chief of Palliative Care and Extensivist Medicine

The UCLA Department of Medicine (DoM) is pleased to announce the appointment of William J. Carroll, MD, FACPas section chief of the UCLA DoM Palliative Care[...]

Joshua N. Khalili, MD Appointed to DoM Chief Wellness Officer

The UCLA Department of Medicine has appointed Joshua N. Khalili, MD to chief wellness officer (CWO) effective April 1. The appointment builds on Dr. Khalili’s outstanding work[...]

Sun M. Yoo, MD, MPH to Depart DoM to Pursue New Leadership Opportunity

The UCLA Department of Medicine (DoM) announces that Sun M. Yoo, MD, MPH, will be departing UCLA Health to assume the role of a founding chief[...]